Comparison of the efficacy of Questran light, a new formulation of cholestyramine powder, to regular Questran in maintaining lowered plasma cholesterol levels

This publication has 13 references indexed in Scilit:

• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
  Archives of internal medicine (1960), 1988
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986
• Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?
  JAMA, 1986
• SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
  The Lancet, 1986
• The Pathogenesis of Atherosclerosis — An Update
  New England Journal of Medicine, 1986
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
  Circulation, 1980
• Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study
  Published by Springer Nature ,1980
• High density lipoprotein as a protective factor against coronary heart disease
  The American Journal of Medicine, 1977